Key result
CADMUS MRI-based classification demonstrates good inter-rater reliability for subtyping SVD-related ICH across two cohorts.
Why the study?
Cerebral small vessel disease is the major cause of intracerebral hemorrhage, but a comprehensive, easily applicable MRI-based classification of intracerebral hemorrhage subtypes according to the presumed underlying small vessel disease was lacking.
Does the novel MRI-based CADMUS classification reproducibly categorize small vessel disease phenotypes and predict 3-month recurrent ICH or ischemic stroke in patients with nontraumatic intracerebral hemorrhage?
Cohort (n=1,493)
Trained raters blinded to outcomes at the time of assessing MRI scans
Yes
Does the novel MRI-based CADMUS classification reproducibly categorize small vessel disease phenotypes and predict 3-month recurrent ICH or ischemic stroke in patients with nontraumatic intracerebral hemorrhage?
Answers are grounded in this paper and cite their sources.
The CADMUS classification provides a reproducible, routine MRI-based framework for subtyping small vessel disease in intracerebral hemorrhage Survivors, revealing that nearly two-thirds of patients harbor mixed CAA and deep perforator arteriopathy features rather than a single pure etiology.
BACKGROUND AND OBJECTIVES: Cerebral small vessel disease (SVD) is the major cause of intracerebral hemorrhage (ICH). There is no comprehensive, easily applicable classification of ICH subtypes according to the presumed underlying SVD using MRI. We developed an MRI-based classification for SVD-related ICH. METHODS: We performed a retrospective study in the prospectively collected Swiss Stroke Registry (SSR, 2013-2019) and the Stroke InvestiGation in North And central London (SIGNAL) cohort. Patients with nontraumatic, SVD-related ICH and available MRI within 3 months were classified as Cerebral Amyloid angiopathy (CAA), Deep perforator arteriopathy (DPA), Mixed CAA-DPA, or Undetermined SVD using hemorrhagic and nonhemorrhagic MRI markers (CADMUS classification). The primary outcome was inter-rater reliability using Gwet's AC1. Secondary outcomes were recurrent ICH/ischemic stroke at 3 months according to the CADMUS phenotype. We performed Firth penalized logistic regressions and competing risk analyses. RESULTS: The SSR cohort included 1,180 patients (median age [interquartile range] 73 [62-80] years, baseline NIH Stroke Scale 6 [2-12], 45.6% lobar hematoma, systolic blood pressure on admission 166 [145-185] mm Hg). The CADMUS phenotypes were as follows: mixed CAA-DPA (n = 751 patients, 63.6%), undetermined SVD (n = 203, 17.2%), CAA (n = 154, 13.1%), and DPA (n = 72, 6.3%), with a similar distribution in the SIGNAL cohort (n = 313). Inter-rater reliability was good (Gwet's AC1 for SSR/SIGNAL 0.69/0.74). During follow-up, 56 patients had 57 events (28 ICH, 29 ischemic strokes). Three-month event rates were comparable between the CADMUS phenotypes. DISCUSSION: CADMUS, a novel MRI-based classification for SVD-associated ICH, is feasible and reproducible and may improve the classification of ICH subtypes in clinical practice and research.
No takes yet. Share an insight, caveat, or question.
Goeldlin et al. (2023) conducted a cohort in Nontraumatic cerebral small vessel disease (SVD)-related intracerebral hemorrhage (ICH) (n=1,493). CADMUS MRI-based small vessel disease classification (CAA, DPA, Mixed CAA-DPA, Undetermined SVD) vs. SMASH-U classification and inter-rater comparison across CADMUS phenotypes was evaluated on Inter-rater reliability of the CADMUS classification using Gwet's AC1 (Gwet's AC1 0.69 (SSR) and 0.74 (SIGNAL), 95% CI 0.53-0.85). The CADMUS MRI-based classification demonstrated good inter-rater reliability for subtyping SVD-related ICH in both the SSR and SIGNAL cohorts.
Synapse has enriched 10 related papers. Consider them for comparative context: